nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SCNN1A—polycystic ovary syndrome	0.644	1	CbGaD
Amiloride—SLC22A2—Metformin—polycystic ovary syndrome	0.0942	0.535	CbGbCtD
Amiloride—SLC22A1—Metformin—polycystic ovary syndrome	0.0818	0.465	CbGbCtD
Amiloride—ASIC2—endometrium—polycystic ovary syndrome	0.00345	0.0449	CbGeAlD
Amiloride—ASIC2—pituitary gland—polycystic ovary syndrome	0.00312	0.0406	CbGeAlD
Amiloride—AOC1—embryo—polycystic ovary syndrome	0.00298	0.0388	CbGeAlD
Amiloride—SLC9A1—embryo—polycystic ovary syndrome	0.00286	0.0371	CbGeAlD
Amiloride—SCNN1G—endometrium—polycystic ovary syndrome	0.00222	0.0289	CbGeAlD
Amiloride—AOC1—endometrium—polycystic ovary syndrome	0.00218	0.0284	CbGeAlD
Amiloride—SCNN1G—pituitary gland—polycystic ovary syndrome	0.00201	0.0262	CbGeAlD
Amiloride—PLAU—endometrium—polycystic ovary syndrome	0.00198	0.0258	CbGeAlD
Amiloride—ASIC1—adipose tissue—polycystic ovary syndrome	0.00197	0.0256	CbGeAlD
Amiloride—SCNN1A—adrenal cortex—polycystic ovary syndrome	0.00194	0.0253	CbGeAlD
Amiloride—SLC9A1—adipose tissue—polycystic ovary syndrome	0.00188	0.0245	CbGeAlD
Amiloride—SCNN1B—endometrium—polycystic ovary syndrome	0.00188	0.0244	CbGeAlD
Amiloride—PLAU—uterus—polycystic ovary syndrome	0.00183	0.0237	CbGeAlD
Amiloride—SCNN1D—adrenal gland—polycystic ovary syndrome	0.0018	0.0234	CbGeAlD
Amiloride—PLAU—pituitary gland—polycystic ovary syndrome	0.00179	0.0233	CbGeAlD
Amiloride—PLAU—adipose tissue—polycystic ovary syndrome	0.00179	0.0232	CbGeAlD
Amiloride—ASIC1—adrenal gland—polycystic ovary syndrome	0.00176	0.0229	CbGeAlD
Amiloride—SCNN1B—adipose tissue—polycystic ovary syndrome	0.00169	0.022	CbGeAlD
Amiloride—SLC9A1—adrenal gland—polycystic ovary syndrome	0.00169	0.022	CbGeAlD
Amiloride—SCNN1G—vagina—polycystic ovary syndrome	0.00167	0.0217	CbGeAlD
Amiloride—ASIC1—female gonad—polycystic ovary syndrome	0.00164	0.0214	CbGeAlD
Amiloride—AOC1—vagina—polycystic ovary syndrome	0.00163	0.0213	CbGeAlD
Amiloride—PLAU—adrenal gland—polycystic ovary syndrome	0.0016	0.0208	CbGeAlD
Amiloride—SCNN1A—uterus—polycystic ovary syndrome	0.0016	0.0208	CbGeAlD
Amiloride—SLC9A1—female gonad—polycystic ovary syndrome	0.00158	0.0205	CbGeAlD
Amiloride—SCNN1A—pituitary gland—polycystic ovary syndrome	0.00157	0.0204	CbGeAlD
Amiloride—SCNN1A—adipose tissue—polycystic ovary syndrome	0.00156	0.0203	CbGeAlD
Amiloride—SCNN1D—endocrine gland—polycystic ovary syndrome	0.00156	0.0203	CbGeAlD
Amiloride—AOC1—endocrine gland—polycystic ovary syndrome	0.00153	0.0199	CbGeAlD
Amiloride—ASIC1—endocrine gland—polycystic ovary syndrome	0.00153	0.0199	CbGeAlD
Amiloride—SCNN1B—adrenal gland—polycystic ovary syndrome	0.00152	0.0197	CbGeAlD
Amiloride—PLAU—female gonad—polycystic ovary syndrome	0.00149	0.0194	CbGeAlD
Amiloride—PLAU—vagina—polycystic ovary syndrome	0.00148	0.0193	CbGeAlD
Amiloride—SLC9A1—endocrine gland—polycystic ovary syndrome	0.00146	0.0191	CbGeAlD
Amiloride—SCNN1B—vagina—polycystic ovary syndrome	0.00141	0.0183	CbGeAlD
Amiloride—SCNN1A—adrenal gland—polycystic ovary syndrome	0.0014	0.0182	CbGeAlD
Amiloride—PLAU—endocrine gland—polycystic ovary syndrome	0.00139	0.0181	CbGeAlD
Amiloride—SCNN1B—endocrine gland—polycystic ovary syndrome	0.00132	0.0171	CbGeAlD
Amiloride—SCNN1A—female gonad—polycystic ovary syndrome	0.00131	0.017	CbGeAlD
Amiloride—SCNN1A—endocrine gland—polycystic ovary syndrome	0.00122	0.0158	CbGeAlD
Amiloride—Heartburn—Metformin—polycystic ovary syndrome	0.000844	0.1	CcSEcCtD
Amiloride—SLC22A4—endometrium—polycystic ovary syndrome	0.000695	0.00904	CbGeAlD
Amiloride—PLAU—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.000646	0.00679	CbGpPWpGaD
Amiloride—SLC9A1—Defective B3GAT3 causes JDSSDHD—HMMR—polycystic ovary syndrome	0.000639	0.00672	CbGpPWpGaD
Amiloride—SLC22A4—pituitary gland—polycystic ovary syndrome	0.000629	0.00818	CbGeAlD
Amiloride—SLC22A4—adipose tissue—polycystic ovary syndrome	0.000626	0.00815	CbGeAlD
Amiloride—PLAU—E2F transcription factor network—RRM2—polycystic ovary syndrome	0.000625	0.00658	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—RACGAP1—polycystic ovary syndrome	0.000613	0.00645	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000606	0.00637	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000606	0.00637	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000606	0.00637	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000606	0.00637	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000606	0.00637	CbGpPWpGaD
Amiloride—PLAU—Blood Clotting Cascade—SERPINE1—polycystic ovary syndrome	0.000603	0.00635	CbGpPWpGaD
Amiloride—SLC22A1—adipose tissue—polycystic ovary syndrome	0.000596	0.00776	CbGeAlD
Amiloride—PLAU—Complement and Coagulation Cascades—PLAT—polycystic ovary syndrome	0.00058	0.00611	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000569	0.00599	CbGpPWpGaD
Amiloride—SLC22A4—adrenal gland—polycystic ovary syndrome	0.000562	0.00731	CbGeAlD
Amiloride—PLAU—ATF-2 transcription factor network—TH—polycystic ovary syndrome	0.000546	0.00574	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—PLAT—polycystic ovary syndrome	0.000544	0.00572	CbGpPWpGaD
Amiloride—SLC22A4—vagina—polycystic ovary syndrome	0.000521	0.00677	CbGeAlD
Amiloride—ASIC2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000515	0.00542	CbGpPWpGaD
Amiloride—SLC22A1—vagina—polycystic ovary syndrome	0.000496	0.00645	CbGeAlD
Amiloride—SLC9A1—ErbB1 downstream signaling—GAB1—polycystic ovary syndrome	0.000493	0.00519	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.000476	0.00501	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.000471	0.00495	CbGpPWpGaD
Amiloride—SLC22A1—endocrine gland—polycystic ovary syndrome	0.000464	0.00603	CbGeAlD
Amiloride—Nasal congestion—Metformin—polycystic ovary syndrome	0.000463	0.0551	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000431	0.00454	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000431	0.00454	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000431	0.00454	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000431	0.00454	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000431	0.00454	CbGpPWpGaD
Amiloride—Pain in extremity—Metformin—polycystic ovary syndrome	0.000421	0.0502	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—INSR—polycystic ovary syndrome	0.000413	0.00434	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—FGF18—polycystic ovary syndrome	0.000408	0.00429	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000399	0.0042	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00039	0.00411	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00039	0.00411	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00039	0.00411	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00039	0.00411	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—ATF1—polycystic ovary syndrome	0.000387	0.00407	CbGpPWpGaD
Amiloride—Cramp muscle—Metformin—polycystic ovary syndrome	0.00038	0.0452	CcSEcCtD
Amiloride—Abdominal distension—Metformin—polycystic ovary syndrome	0.000367	0.0436	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—PLAT—polycystic ovary syndrome	0.000366	0.00385	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—polycystic ovary syndrome	0.00036	0.00378	CbGpPWpGaD
Amiloride—Angina pectoris—Metformin—polycystic ovary syndrome	0.000355	0.0422	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TCF7L2—polycystic ovary syndrome	0.000348	0.00367	CbGpPWpGaD
Amiloride—SLC9A1—G Protein Signaling Pathways—GNAS—polycystic ovary syndrome	0.000343	0.00361	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—HMMR—polycystic ovary syndrome	0.000343	0.00361	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—NR3C1—polycystic ovary syndrome	0.000342	0.0036	CbGpPWpGaD
Amiloride—Neutropenia—Metformin—polycystic ovary syndrome	0.000341	0.0405	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TCF7L2—polycystic ovary syndrome	0.00033	0.00348	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—INS—polycystic ovary syndrome	0.000298	0.00314	CbGpPWpGaD
Amiloride—Bradycardia—Metformin—polycystic ovary syndrome	0.000297	0.0353	CcSEcCtD
Amiloride—PLAU—Hemostasis—GP1BB—polycystic ovary syndrome	0.000296	0.00312	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000284	0.00299	CbGpPWpGaD
Amiloride—PLAU—Complement and Coagulation Cascades—SERPINE1—polycystic ovary syndrome	0.000274	0.00288	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—IGF1—polycystic ovary syndrome	0.00027	0.00284	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000257	0.00271	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—BAX—polycystic ovary syndrome	0.000253	0.00266	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—BCL2—polycystic ovary syndrome	0.000252	0.00265	CbGpPWpGaD
Amiloride—Flatulence—Metformin—polycystic ovary syndrome	0.00025	0.0298	CcSEcCtD
Amiloride—Muscle spasms—Metformin—polycystic ovary syndrome	0.000244	0.029	CcSEcCtD
Amiloride—PLAU—Beta3 integrin cell surface interactions—VEGFA—polycystic ovary syndrome	0.000243	0.00255	CbGpPWpGaD
Amiloride—Tremor—Metformin—polycystic ovary syndrome	0.000238	0.0283	CcSEcCtD
Amiloride—PLAU—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.000231	0.00243	CbGpPWpGaD
Amiloride—Palpitations—Metformin—polycystic ovary syndrome	0.000224	0.0267	CcSEcCtD
Amiloride—Chest pain—Metformin—polycystic ovary syndrome	0.000216	0.0257	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000215	0.00226	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—IL6—polycystic ovary syndrome	0.000213	0.00224	CbGpPWpGaD
Amiloride—Shock—Metformin—polycystic ovary syndrome	0.000204	0.0243	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.0002	0.0021	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NMNAT3—polycystic ovary syndrome	0.000199	0.00209	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PDE3B—polycystic ovary syndrome	0.000199	0.00209	CbGpPWpGaD
Amiloride—Anorexia—Metformin—polycystic ovary syndrome	0.000197	0.0235	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—IRS1—polycystic ovary syndrome	0.000191	0.00201	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—polycystic ovary syndrome	0.000189	0.00199	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000189	0.0225	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—INS—polycystic ovary syndrome	0.000188	0.00198	CbGpPWpGaD
Amiloride—Paraesthesia—Metformin—polycystic ovary syndrome	0.000186	0.0221	CcSEcCtD
Amiloride—Dyspnoea—Metformin—polycystic ovary syndrome	0.000185	0.022	CcSEcCtD
Amiloride—Somnolence—Metformin—polycystic ovary syndrome	0.000184	0.0219	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000183	0.00192	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000183	0.00192	CbGpPWpGaD
Amiloride—Dyspepsia—Metformin—polycystic ovary syndrome	0.000182	0.0217	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IGF1—polycystic ovary syndrome	0.000182	0.00191	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000181	0.0019	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—SLC2A4—polycystic ovary syndrome	0.00018	0.0019	CbGpPWpGaD
Amiloride—Decreased appetite—Metformin—polycystic ovary syndrome	0.00018	0.0214	CcSEcCtD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00018	0.00189	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000179	0.0213	CcSEcCtD
Amiloride—Fatigue—Metformin—polycystic ovary syndrome	0.000179	0.0213	CcSEcCtD
Amiloride—Constipation—Metformin—polycystic ovary syndrome	0.000177	0.0211	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—VEGFA—polycystic ovary syndrome	0.000177	0.00186	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—AKT2—polycystic ovary syndrome	0.000176	0.00186	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—SERPINE1—polycystic ovary syndrome	0.000173	0.00182	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—VEGFA—polycystic ovary syndrome	0.000172	0.00181	CbGpPWpGaD
Amiloride—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000171	0.0203	CcSEcCtD
Amiloride—PLAU—Hemostasis—RACGAP1—polycystic ovary syndrome	0.00017	0.00179	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000169	0.0202	CcSEcCtD
Amiloride—SLC9A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000167	0.00175	CbGpPWpGaD
Amiloride—Abdominal pain—Metformin—polycystic ovary syndrome	0.000164	0.0195	CcSEcCtD
Amiloride—ASIC1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000163	0.00171	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000163	0.00171	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000163	0.00171	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000163	0.00171	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000163	0.00171	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—BCL2—polycystic ovary syndrome	0.000159	0.00167	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—BCL2—polycystic ovary syndrome	0.000154	0.00162	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000153	0.00161	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SUOX—polycystic ovary syndrome	0.000152	0.0016	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000152	0.0016	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000151	0.00159	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000151	0.00159	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000151	0.00159	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000151	0.00159	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000151	0.00159	CbGpPWpGaD
Amiloride—Asthenia—Metformin—polycystic ovary syndrome	0.000149	0.0177	CcSEcCtD
Amiloride—Pruritus—Metformin—polycystic ovary syndrome	0.000147	0.0174	CcSEcCtD
Amiloride—Diarrhoea—Metformin—polycystic ovary syndrome	0.000142	0.0169	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000142	0.00149	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000138	0.00146	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000138	0.00146	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000138	0.00146	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000138	0.00146	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000138	0.00146	CbGpPWpGaD
Amiloride—Dizziness—Metformin—polycystic ovary syndrome	0.000137	0.0163	CcSEcCtD
Amiloride—Vomiting—Metformin—polycystic ovary syndrome	0.000132	0.0157	CcSEcCtD
Amiloride—Rash—Metformin—polycystic ovary syndrome	0.000131	0.0155	CcSEcCtD
Amiloride—Dermatitis—Metformin—polycystic ovary syndrome	0.00013	0.0155	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	0.00013	0.00137	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00013	0.00137	CbGpPWpGaD
Amiloride—Headache—Metformin—polycystic ovary syndrome	0.00013	0.0154	CcSEcCtD
Amiloride—Nausea—Metformin—polycystic ovary syndrome	0.000123	0.0146	CcSEcCtD
Amiloride—SLC9A1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00012	0.00127	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TEAD2—polycystic ovary syndrome	0.00012	0.00127	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000118	0.00124	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000116	0.00122	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000116	0.00122	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000116	0.00122	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000116	0.00122	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000116	0.00122	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL6—polycystic ovary syndrome	0.000114	0.0012	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000107	0.00113	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PLAT—polycystic ovary syndrome	0.000104	0.00109	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPL37A—polycystic ovary syndrome	0.000103	0.00108	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000101	0.00106	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	9.98e-05	0.00105	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HMMR—polycystic ovary syndrome	9.72e-05	0.00102	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SRD5A1—polycystic ovary syndrome	9.57e-05	0.00101	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—STAR—polycystic ovary syndrome	9.13e-05	0.000961	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	9.13e-05	0.00096	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	8.64e-05	0.000909	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	8.56e-05	0.0009	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	8.22e-05	0.000865	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—polycystic ovary syndrome	8.22e-05	0.000865	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMMR—polycystic ovary syndrome	8.14e-05	0.000856	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	8.05e-05	0.000847	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKR1C1—polycystic ovary syndrome	8e-05	0.000842	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—GNAS—polycystic ovary syndrome	7.98e-05	0.00084	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	7.98e-05	0.000839	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HSD3B1—polycystic ovary syndrome	7.76e-05	0.000817	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.66e-05	0.000806	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF18—polycystic ovary syndrome	7.43e-05	0.000781	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RBP4—polycystic ovary syndrome	7.37e-05	0.000775	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LHB—polycystic ovary syndrome	7.08e-05	0.000745	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HSD3B2—polycystic ovary syndrome	6.92e-05	0.000728	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GAB1—polycystic ovary syndrome	6.78e-05	0.000714	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKR1C1—polycystic ovary syndrome	6.7e-05	0.000705	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NAMPT—polycystic ovary syndrome	6.61e-05	0.000695	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SULT2A1—polycystic ovary syndrome	6.17e-05	0.000649	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKR1C3—polycystic ovary syndrome	6.16e-05	0.000648	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	6.16e-05	0.000648	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TNRC6B—polycystic ovary syndrome	6.07e-05	0.000638	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—RRM2—polycystic ovary syndrome	5.97e-05	0.000629	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	5.79e-05	0.000609	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—YAP1—polycystic ovary syndrome	5.76e-05	0.000606	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	5.74e-05	0.000604	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	5.57e-05	0.000586	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NAMPT—polycystic ovary syndrome	5.53e-05	0.000582	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP11A1—polycystic ovary syndrome	5.46e-05	0.000575	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	5.39e-05	0.000568	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TCF7L2—polycystic ovary syndrome	5.19e-05	0.000546	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	5.19e-05	0.000546	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF1—polycystic ovary syndrome	5.17e-05	0.000544	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT2—polycystic ovary syndrome	5.17e-05	0.000544	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKR1C3—polycystic ovary syndrome	5.16e-05	0.000543	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	5.12e-05	0.000539	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SLC2A4—polycystic ovary syndrome	5.11e-05	0.000537	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP17A1—polycystic ovary syndrome	5.08e-05	0.000534	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.91e-05	0.000517	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SERPINE1—polycystic ovary syndrome	4.91e-05	0.000517	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PRL—polycystic ovary syndrome	4.87e-05	0.000512	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	4.77e-05	0.000502	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.57e-05	0.000481	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—CAMK2D—polycystic ovary syndrome	4.43e-05	0.000467	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TH—polycystic ovary syndrome	4.4e-05	0.000462	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC2A4—polycystic ovary syndrome	4.28e-05	0.00045	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.18e-05	0.00044	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—CAMK2D—polycystic ovary syndrome	4.13e-05	0.000435	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NCOR1—polycystic ovary syndrome	4.08e-05	0.000429	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP19A1—polycystic ovary syndrome	4.02e-05	0.000423	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NRG1—polycystic ovary syndrome	4.01e-05	0.000421	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—DLG4—polycystic ovary syndrome	3.92e-05	0.000413	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	3.89e-05	0.000409	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—DLG4—polycystic ovary syndrome	3.66e-05	0.000385	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	3.62e-05	0.000381	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NMNAT3—polycystic ovary syndrome	3.61e-05	0.00038	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTHFR—polycystic ovary syndrome	3.61e-05	0.00038	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GNAS—polycystic ovary syndrome	3.59e-05	0.000378	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.51e-05	0.000369	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IRS2—polycystic ovary syndrome	3.43e-05	0.000361	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NCOR1—polycystic ovary syndrome	3.42e-05	0.00036	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—polycystic ovary syndrome	3.38e-05	0.000355	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NMNAT3—polycystic ovary syndrome	3.36e-05	0.000354	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LPCAT2—polycystic ovary syndrome	3.3e-05	0.000347	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SUOX—polycystic ovary syndrome	3.3e-05	0.000347	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1A1—polycystic ovary syndrome	3.24e-05	0.000341	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LPCAT2—polycystic ovary syndrome	3.08e-05	0.000324	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SUOX—polycystic ovary syndrome	3.08e-05	0.000324	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ISYNA1—polycystic ovary syndrome	3.07e-05	0.000323	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—polycystic ovary syndrome	3.02e-05	0.000318	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IRS1—polycystic ovary syndrome	3e-05	0.000315	CbGpPWpGaD
Amiloride—SLC9A1—Disease—INS—polycystic ovary syndrome	2.87e-05	0.000302	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ISYNA1—polycystic ovary syndrome	2.86e-05	0.000301	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT2—polycystic ovary syndrome	2.77e-05	0.000292	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—polycystic ovary syndrome	2.63e-05	0.000277	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TEAD2—polycystic ovary syndrome	2.61e-05	0.000274	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKR1C2—polycystic ovary syndrome	2.61e-05	0.000274	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—polycystic ovary syndrome	2.45e-05	0.000258	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TEAD2—polycystic ovary syndrome	2.43e-05	0.000256	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKR1C2—polycystic ovary syndrome	2.43e-05	0.000256	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—POMC—polycystic ovary syndrome	2.42e-05	0.000254	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—INS—polycystic ovary syndrome	2.4e-05	0.000253	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.32e-05	0.000244	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PNPLA2—polycystic ovary syndrome	2.19e-05	0.00023	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.17e-05	0.000228	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.16e-05	0.000227	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SRD5A1—polycystic ovary syndrome	2.07e-05	0.000218	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PNPLA2—polycystic ovary syndrome	2.04e-05	0.000214	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.01e-05	0.000212	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	1.98e-05	0.000208	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.98e-05	0.000208	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	1.93e-05	0.000203	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	1.84e-05	0.000194	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.84e-05	0.000194	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	1.76e-05	0.000185	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.68e-05	0.000177	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.66e-05	0.000174	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	1.64e-05	0.000173	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	1.57e-05	0.000165	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.55e-05	0.000163	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	1.53e-05	0.000161	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.5e-05	0.000158	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.45e-05	0.000153	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	1.43e-05	0.00015	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	1.4e-05	0.000147	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	1.35e-05	0.000142	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.34e-05	0.00014	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	1.29e-05	0.000136	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—polycystic ovary syndrome	1.25e-05	0.000132	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	1.25e-05	0.000131	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	1.24e-05	0.000131	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	1.21e-05	0.000127	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	1.2e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.18e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	1.16e-05	0.000122	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.12e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	1.12e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	1.1e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.1e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.04e-05	0.00011	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.02e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TH—polycystic ovary syndrome	9.51e-06	0.0001	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	9.25e-06	9.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TH—polycystic ovary syndrome	8.87e-06	9.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	8.7e-06	9.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	8.63e-06	9.08e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	8.11e-06	8.53e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	7.77e-06	8.17e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	7.4e-06	7.78e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	7.24e-06	7.62e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.01e-06	7.38e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	6.9e-06	7.25e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	6.54e-06	6.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	6.54e-06	6.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	6.09e-06	6.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	5.3e-06	5.58e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	5.23e-06	5.5e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—INS—polycystic ovary syndrome	5.2e-06	5.47e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	4.94e-06	5.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	4.87e-06	5.13e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—INS—polycystic ovary syndrome	4.85e-06	5.1e-05	CbGpPWpGaD
